1. Date of Event: 115/06/26 2. Company Name: Meiji Chemical & Pharmaceutical Co., Ltd. 3. Relationship to Company: Parent Company 4. Cross-shareholding Ratio: 100% 5. Reason for Occurrence: In alignment with the company's current operational status, the USD 15 million funding loan facility to Alvogen Korea Holdings Ltd. has been canceled. 6. Countermeasures: Not applicable 7. Other Matters to be Disclosed: As the entity involved is a publicly listed company, this material information also qualifies as a matter of significant impact on shareholders' equity or securities prices under Article 7, Clause 9 of the Enforcement Rules of the Securities Trading Act. No additional disclosures are required. Keywords: Material Information

FACT BOX

  • Source: PR Times
  • Category: News
  • Organizations: Alvogen Korea Holdings Ltd.
  • Dates in source: 115/06/26